Oncology/Cancer Drugs Market by Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Hormonal Therapy) and Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025 Update Available On-Demand

Abstract
Apex Market Research has published a new report titled ”Global OncologyorCancer Drugs Market share, forecast data, In-Depth Analysis, and Forecast, 2020-2027”. According to the report, The global oncology/cancer drugs market was valued at $97,401 million in 2017, and is estimated to reach at $176,509 million by 2025, registering a CAGR of 7.6% The report offers in-depth insights, revenue details, and other vital information regarding the global OncologyorCancer Drugs market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.

Attractive Opportunities in the OncologyorCancer Drugs market

The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Global OncologyorCancer Drugs market report offers in-depth insights, revenue details, and other vital information regarding the global OncologyorCancer Drugs market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period.
It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest shareholder of OncologyorCancer Drugs market. The major players operating into OncologyorCancer Drugs Market include: AbbVie Inc.
Astellas Pharma Inc.
AstraZeneca PLC
Bristol-Myers Squibb Company
Celgene Corporation
f. Hoffmann-La Roche ltd.
Johnson & Johnson (Janssen Global Services LLC
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Scope Of the Report
Report Parameters Details of Parameter
Market Size 2020-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value USD
Covered Segments Drug Class Type, Indication
Region Covered North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)
This research report categorizes the OncologyorCancer Drugs market to forecast revenues and analyze trends in each of the following submarkets:

By Drug Class Type

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy

By Indication

  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Liver Cancer
  • Esophagus Cancer
  • Cervical Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Other Cancers
By geography, this market has been segregated into five regions with revenue and growth rate of OncologyorCancer Drugs from 2020 to 2027,
There are 13 chapters to put on view for OncologyorCancer Drugs Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: OncologyorCancer Drugs Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 OncologyorCancer Drugs Market Overview 1.1.1 OncologyorCancer Drugs Product Scope 1.1.2 Market Status and Outlook 1.2 Global OncologyorCancer Drugs Market Size and Analysis by Regions (2015-2019) 1.2.1 North America OncologyorCancer Drugs Market Status and Outlook 1.2.2 EU OncologyorCancer Drugs Market Status and Outlook 1.2.3 Japan OncologyorCancer Drugs Market Status and Outlook 1.2.4 China OncologyorCancer Drugs Market Status and Outlook 1.2.5 India OncologyorCancer Drugs Market Status and Outlook 1.2.6 Southeast Asia OncologyorCancer Drugs Market Status and Outlook 1.3 Global OncologyorCancer Drugs Market Segment Drug Class Type
1.3.1 Introduction
1.3.1.1 Market Estimates And Forecast 2015-2027
1.3.2 Chemotherapy
1.3.2.1 Market Estimates And Forecast By Country, 2015-2027
1.3.3 Targeted Therapy
1.3.3.1 Market Estimates And Forecast By Country, 2015-2027
1.3.4 Immunotherapy (Biologic Therapy)
1.3.4.1 Market Estimates And Forecast By Country, 2015-2027
1.3.5 Hormonal Therapy
1.3.5.1 Market Estimates And Forecast By Country, 2015-2027
1.4 Global OncologyorCancer Drugs Market Segment Indication
1.4.1 Introduction
1.4.1.1 Market Estimates And Forecast 2015-2027
1.4.2 Lung Cancer
1.4.2.1 Market Estimates And Forecast By Country, 2015-2027
1.4.3 Stomach Cancer
1.4.3.1 Market Estimates And Forecast By Country, 2015-2027
1.4.4 Colorectal Cancer
1.4.4.1 Market Estimates And Forecast By Country, 2015-2027
1.4.5 Breast Cancer
1.4.5.1 Market Estimates And Forecast By Country, 2015-2027
1.4.6 Prostate Cancer
1.4.6.1 Market Estimates And Forecast By Country, 2015-2027
1.4.7 Liver Cancer
1.4.7.1 Market Estimates And Forecast By Country, 2015-2027
1.4.8 Esophagus Cancer
1.4.8.1 Market Estimates And Forecast By Country, 2015-2027
1.4.9 Cervical Cancer
1.4.9.1 Market Estimates And Forecast By Country, 2015-2027
1.4.10 Kidney Cancer
1.4.10.1 Market Estimates And Forecast By Country, 2015-2027
1.4.11 Bladder Cancer
1.4.11.1 Market Estimates And Forecast By Country, 2015-2027
1.4.12 Other Cancers
1.4.12.1 Market Estimates And Forecast By Country, 2015-2027
Chapter 2 Global OncologyorCancer Drugs Competition Analysis by Players 2.1 Global OncologyorCancer Drugs Market Size (Million USD) by Players (2015-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 AbbVie Inc. 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 AbbVie Inc., OncologyorCancer Drugs Revenue (Million USD) (2015-2019) 3.1.5 Recent Developments 3.2 Astellas Pharma Inc. 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Astellas Pharma Inc., OncologyorCancer Drugs Revenue (Million USD) (2015-2019) 3.2.5 Recent Developments 3.3 AstraZeneca PLC 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 AstraZeneca PLC, OncologyorCancer Drugs Revenue (Million USD) (2015-2019) 3.3.5 Recent Developments 3.4 Bristol-Myers Squibb Company 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Bristol-Myers Squibb Company, OncologyorCancer Drugs Revenue (Million USD) (2015-2019) 3.4.5 Recent Developments 3.5 Celgene Corporation 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Celgene Corporation, OncologyorCancer Drugs Revenue (Million USD)(2015-2019) 3.5.5 Recent Developments 3.6 f. Hoffmann-La Roche ltd. 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 f. Hoffmann-La Roche ltd., OncologyorCancer Drugs Revenue (Million USD)(2015-2019) 3.6.5 Recent Developments 3.7 Johnson & Johnson (Janssen Global Services LLC 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Johnson & Johnson (Janssen Global Services LLC, OncologyorCancer Drugs Revenue (Million USD)(2015-2019) 3.7.5 Recent Developments 3.8 Merck & Co. Inc. 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Merck & Co. Inc., OncologyorCancer Drugs Revenue (Million USD) (2015-2019) 3.8.5 Recent Developments 3.9 Novartis AG 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Novartis AG, OncologyorCancer Drugs Revenue (Million USD) (2015-2019) 3.9.5 Recent Developments 3.10 Pfizer Inc. 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Pfizer Inc., OncologyorCancer Drugs Revenue (Million USD) (2015-2019) 3.10.5 Recent Developments Chapter 4 Global OncologyorCancer Drugs Market Size Type (2015-2019) 4.1 Global OncologyorCancer Drugs Market Size by Type (2015-2019) Chapter 5 Global OncologyorCancer Drugs Market Size Application (2015-2019) 5.1 Global OncologyorCancer Drugs Market Size by Application (2015-2019) 5.2 Potential Application of OncologyorCancer Drugs in Future 5.3 Top Consumer / End Users of OncologyorCancer Drugs Chapter 6 North America OncologyorCancer Drugs Development Status and Outlook 6.1 North America OncologyorCancer Drugs Market Size (2015-2019) 6.2 North America OncologyorCancer Drugs Market Size by Application (2015-2019) Chapter 7 EU OncologyorCancer Drugs Development Status and Outlook 7.1 EU OncologyorCancer Drugs Market Size (2015-2019) 7.2 EU OncologyorCancer Drugs Market Size by Application (2015-2019) Chapter 8 Japan OncologyorCancer Drugs Development Status and Outlook 8.1 Japan OncologyorCancer Drugs Market Size (2015-2019) 8.2 Japan OncologyorCancer Drugs Market Size by Application (2015-2019) Chapter 9 China OncologyorCancer Drugs Development Status and Outlook 9.1 China OncologyorCancer Drugs Market Size and Forecast (2015-2019) 9.2 China OncologyorCancer Drugs Market Size by Application (2015-2019) Chapter 10 India OncologyorCancer Drugs Development Status and Outlook 10.1 India OncologyorCancer Drugs Market Size and Forecast (2015-2019) 10.2 India OncologyorCancer Drugs Market Size by Application (2015-2019) Chapter 11 Southeast Asia OncologyorCancer Drugs Development Status and Outlook 11.1 Southeast Asia OncologyorCancer Drugs Market Size and Forecast (2015-2019) 11.2 Southeast Asia OncologyorCancer Drugs Market Size by Application (2015-2019) Chapter 12 Market Forecast by Regions and Application (2020-2027) 12.1 Global OncologyorCancer Drugs Market Size (Million USD) by Regions (2020-2027) 12.1. North America OncologyorCancer Drugs Revenue and Growth Rate (2020-2027) 12.1.2 EU OncologyorCancer Drugs Revenue and Growth Rate (2020-2027) 12.1.3 China OncologyorCancer Drugs Revenue and Growth Rate (2020-2027) 12.1.4 Japan OncologyorCancer Drugs Revenue and Growth Rate (2020-2027) 12.1.5 Southeast Asia OncologyorCancer Drugs Revenue and Growth Rate (2020-2027) 12.1.6 India OncologyorCancer Drugs Revenue and Growth Rate (2020-2027) 12.2 Global OncologyorCancer Drugs Market Size by Application (2020-2027) Chapter 13 OncologyorCancer Drugs Market Dynamics 13.1 OncologyorCancer Drugs Market Opportunities 13.2 OncologyorCancer Drugs Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 OncologyorCancer Drugs Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 OncologyorCancer Drugs Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
1298

1135

OUR CLIENT